Editorial: Cardiorenal dysregulation in endocrine disorders: innovative mechanisms and therapeutic interventions
Saved in:
Main Authors: | Noha M. Shawky (Author), Eman Soliman (Author), Abdel A. Abdel-Rahman (Author), Samar Rezq (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design and synthesis of novel quinazolinones conjugated ibuprofen, indole acetamide, or thioacetohydrazide as selective COX-2 inhibitors: anti-inflammatory, analgesic and anticancer activities
by: Asmaa Sakr, et al.
Published: (2021) -
Triple targeting of mutant EGFRL858R/T790M, COX-2, and 15-LOX: design and synthesis of novel quinazolinone tethered phenyl urea derivatives for anti-inflammatory and anticancer evaluation
by: Hend Kothayer, et al.
Published: (2023) -
CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome
by: Cankun Zheng, et al.
Published: (2022) -
Update on the Classification and Pathophysiological Mechanisms of Pediatric Cardiorenal Syndromes
by: Giorgia Ceravolo, et al.
Published: (2021) -
Pathogenicity of Endocrine Dysregulation in Autism: The Role of the Melanin-Concentrating Hormone System
by: Adam Swierczynski
Published: (2019)